FDA approves AbbVie's (ABBV) pivekimab sunirine-pvzy for blastic plasmacytoid dendritic cell neoplasm

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

State Street (STT) says it is planning a strategic update in July, to focus on powering franchises

KKR (KKR) exec says wealth and private demand remains resilient, despite the headlines

FDA approves AbbVie's (ABBV) pivekimab sunirine-pvzy for blastic plasmacytoid dendritic cell neoplasm

TREASURY WRAP: T-NOTE FUTURES (M6) SETTLE 2+ TICKS HIGHER AT 109-29

US FX WRAP: Dollar traded flat ahead of Thursday PCE; NZD outperforms on hawkish RBNZ hold

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free